Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – July 12, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) is pleased...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – July 6, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) is pleased...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – June 24, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) is pleased...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – June 17, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) is pleased...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – June 10, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) is pleased...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – May 30, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) is proud...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – May 17, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan“) is pleased...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – May 11, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) is pleased...
A Case Report Published in Frontiers in Veterinary Science Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – April 29, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE:...
Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – April 11, 2022) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”), is pleased...